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Signal integrationThe causal and interplay mechanisms of Single Nucleotide Polymorphisms (SNPs) associated with com-
plex diseases (complex disease SNPs) investigated in genome-wide association studies (GWAS) at the
transcriptional level (mRNA) are poorly understood despite recent advancements such as discoveries
reported in the Encyclopedia of DNA Elements (ENCODE) and Genotype-Tissue Expression (GTex).
Protein interaction network analyses have successfully improved our understanding of both single gene
diseases (Mendelian diseases) and complex diseases. Whether the mRNAs downstream of complex dis-
ease genes are central or peripheral in the genetic information flow relating DNA to mRNA remains
unclear and may be disease-specific. Using expression Quantitative Trait Loci (eQTL) that provide DNA
to mRNA associations and network centrality metrics, we hypothesize that we can unveil the systems
properties of information flow between SNPs and the transcriptomes of complex diseases. We compare
different conditions such as naïve SNP assignments and stringent linkage disequilibrium (LD) free assign-
ments for transcripts to remove confounders from LD. Additionally, we compare the results from eQTL
networks between lymphoblastoid cell lines and liver tissue. Empirical permutation resampling
(p < 0.001) and theoretic Mann–Whitney U test (p < 1030) statistics indicate that mRNAs corresponding
to complex disease SNPs via eQTL associations are likely to be regulated by a larger number of SNPs than
expected. We name this novel property mRNA hubness in eQTL networks, and further term mRNAs with
high hubness asmaster integrators.mRNA master integrators receive and coordinate the perturbation sig-
nals from large numbers of polymorphisms and respond to the personal genetic architecture integra-
tively. This genetic signal integration contrasts with the mechanism underlying some Mendelian
diseases, where a genetic polymorphism affecting a single protein hub produces a divergent signal that
affects a large number of downstream proteins. Indeed, we verify that this property is independent of the
hubness in protein networks for which these mRNAs are transcribed. Our findings provide novel insights
into the pleiotropy of mRNAs targeted by complex disease polymorphisms and the architecture of the
information flow between the genetic polymorphisms and transcriptomes of complex diseases.
 2015 The Authors. Published by Elsevier Inc. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Genome-wide association studies (GWAS) have successfully
discovered many genetic variants associated with the development
and progression of diverse classes of complex diseases. However,
existing knowledge about the mechanisms of complex diseases islimited. One important reason may be that GWASs focus primarily
on finding mere associations of genetic variants with traits, while
ignoring the underlying architecture of complex diseases. Many
common single nucleotide polymorphisms (SNPs) are associated
with complex diseases, but each SNP contributes only a small
amount to the disease risk. The observation of additive and syner-
gistic effects implies the presence of crosstalk and network of
complicated regulatory mechanisms of SNPs [1–3] that can be
perceived as local perturbations. However, identifying and
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the underlying complex diseases, remains a challenge.
During the past decade, network analyses have increased our
understanding about the underlying mechanisms of the behavior
of biological systems and their higher order properties such as
their topological ones [4,5]. Centrality, as a basic topological prop-
erty, measures the connectivity of a node to other nodes, which
represents the relative impact of that node in the network upon
its perturbation. When applying this framework to a biological net-
work: (i) proteins are modeled as nodes in protein–protein interac-
tion (PPI) networks, while (ii) both mRNAs and SNPs are nodes in
expression quantitative trait loci (eQTL) networks. Edges relating
the molecules of life are protein interactions in PPIs and statistical
associations between SNPs and mRNAs in eQTL networks. The
degree of a node is the number of connections it has to other nodes,
and nodes with the highest degree are called ‘‘hubs”. In PPI net-
works, genetic loss of function of a hub protein can be embryolog-
ically lethal (essential genes) as shown in knock down mouse
models [6,7], while genetic gain of function of the corresponding
hub proteins (e.g. transcriptional factors) are known to increase
cancer progression [8]. Hub proteins of non-essential genes are
enriched in Mendelian diseases, with large effect sizes [7]. Mis-
sense mutations of hub protein may lead to a more subtle alter-
ation of the biological function and has been more frequently
seen in Mendelian diseases [9]. On the other hand, for other com-
plex diseases (e.g. diabetes mellitus, hypertension), the individual
impact from a polymorphism usually is not fatal, therefore, genes
associated with these diseases are generally found peripherally in
the PPI network [10,11].
Complex disease single nucleotide polymorphisms are consid-
ered upstream discrete inputs in genetic models with outputs
being multiple quantitative continuous phenotypes that character-
ize a disease [12]. In genetic models combined with downstream
protein interaction networks, the polymorphisms or mutations of
a gene may initiate an edgetic perturbation and cause a Mendelian
disorder [13,14]. While edgetic effects are much more subtle in
complex diseases, previous studies of biological networks identi-
fied an enrichment of intragenic SNPs in the shortest paths of com-Fig. 1. Divergent and convergent (integrator) hubs in biological networks. Existing stud
downstream molecules of life, as exemplified by microRNAs (Panel A), essential signal
complex diseases may interact and enrich downstream mRNA master integrators, which
phenotype (Panel D). Of note, divergent hubs have an excessive number of out degrees w
the directional networks.plex disease associated host genes [15]. Our prior research also
revealed the enrichment of the polymorphisms coding for hub pro-
teins in PPI networks of complex diseases [16]. This finding sug-
gests some convergence of complex and Mendelian diseases at
the protein interaction level [17]. We applied this clue to Alzhei-
mer’s disease and indeed found the candidate genes sharing
molecular mechanisms between Mendelian and complex diseases
coupled with shortest PPI path strategies [18]. Nevertheless,
whether hubness is an intrinsic property of biological networks
underpinning complex polymorphisms is not widely accepted [19].
GWAS demonstrate the difference between complex diseases
and single gene diseases, as dozens of polymorphisms rarely
explain more than 10% of the phenotypes of the former while a sin-
gle polymorphism usually determines the key phenotypes of the
latter. However, there is a lack of information models that take into
account the downstream transcriptomic effect of complex diseases
genetics to provide formal insight about their genetic architecture.
To our knowledge, previous studies focus on PPI networks and
divergent centrality of hub proteins. For instance, a hub in a gene
co-expression network, such as a microRNA (e.g. miR-204 [20]),
can downregulate the expression of many downstream genes, act-
ing as a divergent inhibitor (Fig. 1A). A hub in a protein signaling
network, such as signal receptor binding protein Ras [21,22]),
may amplify a signal it receives and activate a series of down-
stream processes through physical protein interactions and post-
translational modifications (Fig. 1B). In a complex disease scenario,
a master regulator SNP may affect the expression of many down-
stream mRNAs [1] (Fig. 1C). However, the mRNAs dysregulated
by SNPs related to complex diseases may behave differently than
other divergent hubs (Fig. 1D). An mRNA hub (e.g. HLA-DQA1
[23]) may combine the perturbation signals from various polymor-
phisms, consequently affecting the regulation of other downstream
mRNAs such that a disease phenotype develops.
Increasing our knowledge of how genetic signals are integrated
(multivariate discrete inputs) is crucial to our understanding of
their downstream impact on disease phenotypes (multivariate
continuous outputs). Biological signal integration has been the
subject of numerous studies, particularly in the context of crosstalkies concentrate on divergent hubs, which inhibit or activate excessive numbers of
ing proteins (Panel B), and master regulator SNPs (Panel C). Genes susceptible to
integrate an excessive number of genetic perturbations, finally leading to a disease
hile convergent hubs (master integrators) have an excessive number of in degrees in
Table 1
Definitions and descriptions of abbreviations and terms.
Abbreviation Definition; descriptions
Centrality The impact of a node in a network; consequence of the
dysregulation of a molecule of life (node) on the function
of the biological network
Edge A connection between two nodes in a graph or network;
e.g. biophysical interaction (edges) between proteins
(nodes)
eQTL Expression Quantitative Trait Loci; e.g. statistical
associations between the a SNP value and the level of
expression of a mRNA
GWAS Genome-wide Association Study; e.g. statistical
association between a SNP value and a trait (e.g. response
to therapy) or disease
Hub; hubness A highly connected node in a network
LCL Lymphoblastoid cell line
LD Linkage disequilibrium; non-random association of alleles
(e.g. SNP values) at different genomic locations
mRNA master
integrator
mRNA associated with a large number of distinct SNPs in
an eQTL network
Node An entity in a network: a molecular of life (e.g. SNP,
mRNA. protein) in a biological network
Pleiotropy One gene that influences two or more unrelated
phenotypes (e.g. diseases)
Polymorphism Genetic variations between individual subjects
PPI Protein–protein interaction (network)
SNP Single Nucleotide Polymorphism; DNA sequence variation
occurring in which a single nucleotide differs among
individual subjects
228 H. Li et al. / Journal of Biomedical Informatics 58 (2015) 226–234between individual signaling pathways [24]. Unsurprisingly, cells
must integrate a large number of signals in order to maintain their
homeostasis and regulate complex cellular processes. Recent stud-
ies shifted their signal integration focus from canonical pathways
to more complex biological networks [25]; however, to our knowl-
edge eQTL networks have not been studied for signal integration.
Few studies report convergent integration for disease genes
from different scales of gene regulation networks [5]. Some net-
work studies indicate the prevalence of the divergent and conver-
gent topology in biological networks as compared to alternatives,
such as densely connected modules [26]. Particularly, these studies
focus more on divergent hubs than on convergent integrative ones
[27]. In this regard, we hypothesize that networks of genomic loci
affecting expression levels of mRNAs would provide novel insight
into systems properties of complex diseases. We concentrate
specifically on expression Quantitative Trait Loci association
(eQTL) [28] networks and investigate whether mRNAs related to
complex disease SNPs are more central than the remaining mRNAs
in the network of eQTL associations. We term the mRNAs related to
an excessive number of SNPs (e.g. top 20%) mRNA master integra-
tors, and use the eQTL data of two human cell types from lym-
phoblastoid (LCL) and liver tissues to examine the enrichment of
mRNA master integrators in the eQTL networks. We further
hypothesize that mRNA master integrators play important roles
in integrating multiple perturbation signals from genetic polymor-
phisms and are closely related to the physiopathology of complex
diseases. Our aim is to reveal a novel type of mRNAmaster integra-
tors that appears to characterize in part systems biology of com-
plex diseases.
2. Methods
The flow of the methodology is illustrated in Fig. 2 and the
abbreviations are in Table 1. Three types of datasets were
employed, with subsequent measurement of mRNA node degreeFig. 2. Schematic diagram of our approach.in eQTL networks and then investigation of the mRNA master inte-
grator enrichment in genes related to complex disease classes and
specific complex diseases. An additional protein interaction dataset
was used to compare the findings in eQTL networks and protein
interaction networks.
2.1. Datasets
Five datasets were employed in this study:
(i) Two SNP-mRNA eQTL datasets derived from lymphoblastoid
cell lines (LCL; B lymphoblast) and liver tissues from Cau-
casian populations were downloaded from SCAN.db [23]
on October 11, 2010 and August 15, 2013, respectively.
The LCL dataset consisted of 4,189,682 associations between
833,004 distinct SNPs and 11,860 mRNAs (p-value 6 104),
and the liver dataset contained 314,545 associations
between 139,814 SNPs and 19,641 mRNAs (p–value 6 10–5).
(ii) SNP-complex disease (or trait) associations were down-
loaded from NHGRI GWAS catalog on May 2012. It com-
prised 7236 associations between 6432 SNPs and 574
complex diseases/traits. These traits were classified into 15
disease classes according to the Maurano et al. [29] curation,
with few additional traits manually curated by the authors
(Supplementary Table 1: http://www.lussierlab.net/publica-
tions/eQTL_centrality/Table-S1-disease-Class.xls).
(iii) Associations of alleles at two loci were assessed by SNP link-
age disequilibrium (LD) [30], which were downloaded from
Hapmap on April 19, 2009 [31]. Only Caucasian LD data
was used.
(iv) Protein interaction data were downloaded from String-DB
[22]. The dataset combined v8.2 and v6.3 for high confidence
protein interactions and was used in our previous study of
protein centrality [16].
2.2. Measurement of centrality in an eQTL association network
An eQTL association network is dependent on a cutoff that
determines the minimal level of statistical significance for each
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tured as a bipartite graph. We defined the hubness centrality mea-
sure of mRNAs according to their respective node degrees in the
eQTL bipartite graph, where the node degree of an mRNA was
defined as the number of SNPs associated with the mRNA with
respect to the significance cutoff.
The measure for hubness of an mRNA may be biased by connec-
tion of LD SNPs in the same ‘‘LD block” to identical mRNAs; we
assumed these should not be repeatedly counted. Therefore, we
defined two different measures for qualifying the hubness of a
given mRNA: (i) the ‘‘unadjusted node degree” that does not take
into account the LD bias and (ii) the ‘‘adjusted node degree” that
clusters the LD SNPs into ‘‘LD blocks” (according to a LD cutoff)
before calculating the number of independent SNPs associated
with a given mRNA. Fig. 3 shows the algorithm used for clustering
the SNPs into the so-called ‘‘LD blocks”.
mRNA hubness was defined as the normalized node degree
(either unadjusted or adjusted) across all mRNAs. The normaliza-
tion procedure first ranked the node degree of all mRNAs in
ascending order and then divided the order number (starting from
1) by the total number of mRNAs. An mRNA with a hubness score
of at least 80% (top 20%) was defined as a master integrator in the
eQTL bipartite network.
2.3. mRNA master integrator enrichment test
We annotated the SNPs to complex disease classes according to
the GWAS and class curation (see Section 2.1). At a given eQTL cut-
off, all SNPs without eQTL associations were excluded from the
enrichment analysis. mRNAs associated with any SNP of a complex
disease in the eQTL associations were annotated as the disease-
class related mRNAs. Some mRNAs annotated to a disease class
overlapped with another class.
The enrichment of mRNA master integrators in a disease class
was investigated in two ways: (i) The hubness of each mRNA was
compared with that of all other mRNAs in the eQTL bipartite net-
work, using a one tail Mann–Whitney U test (function ‘‘wilcox.test”
in R) to examine whether the median mRNA hubness in this class
was significantly larger than that in the background (consisting of
the scores of the hubness of all mRNAs not in the class). Enrichment
of themRNAmaster integrators of complex diseases as a whole was
done similarly. (ii) The proportion of mRNA master integrators in
the class was examined, with a deviation of expected value 20%
as a direct indicator of master integrator enrichment. We assessed
the significance of the proportion of mRNA master integrators in
each complex disease class through randomization. A bipartite net-
work was constructed such that the two layers were composed of
SNPs and mRNAs, respectively. We then calculated the proportion
of master integrators for each class of diseases. Afterwards, we gen-Fig. 3. Clustering algorithm used for creating the ‘‘LD blocks” of SNPs with high LD values
s represents the minimum average LD (r2) of an SNP cluster.erated 1000 control distributions for each disease class by (1)
resampling SNPs without replacement equal in numbers to those
of GWAS studies subsumed by the disease class and (2) randomly
resampling mRNAs equal in number to that in the observed eQTL
network. Following this, we computed the proportion of master
integrators in each of the randomly generated gene sets, thus giving
rise to a null distribution. Subsequently, we calculated the number
of times the randomly generated master integrator proportion val-
ues exceeded that of the observed ones, and assigned a p-value to
the observed value accordingly. We repeated the same process sep-
arately for all of the different classes of diseases.2.4. Comparison of eQTL centrality to protein centrality
To study the centrality of mRNAs and their coding protein prod-
ucts comparatively, we computed the hubness of proteins from PPI
networks. Per convention, proteins with top proportions (20%) of
hubness were defined as hubs. Then, we compared eQTL mRNA
hubness and corresponding protein hubness of mRNAs associated
with complex diseases, each disease class, and each specific disease
(See Section 2.1) using Fisher’s Exact Test (FET) for enrichment and
Spearman method for correlation at various centrality cutoffs.3. Results
eQTL analysis shows how the expression values of a large num-
ber of mRNAs are altered and associated with each class of com-
plex diseases. We observed that in LCL cell lines, 6301 (53%),
1095 (9.4%) and 160 (2.1%) of all mRNAs are related to complex
diseases at the eQTL p-value cutoff values of 104, 105 and 106,
respectively. We also observed the same pattern in liver tissue
eQTL data, in which 1638 out of 19,641 (8.3%) and 362 out of
12,851 (2.8%) remained associated with complex diseases at cutoff
values of 105 and 10–6, respectively. After examining the propor-
tion of master integrators (the top 20% ofmRNAs with highest node
connectivity values) among these mRNAs at different p-value cut-
offs, we noticed a higher ratio than the expected value of 20%.
Specifically, there are 31.3% (Fig. 4A), 54.7%, and 65.6% of master
integrators for LCL cell lines at eQTL p-value cutoff of 104, 105
and 106, respectively, and 47.3% and 53.9% for liver tissue at p-
value 6 105 and 106, respectively. Importantly, we found that
across the range of these different p-value cutoffs the median hub-
ness of mRNAs within a complex disease class is significantly
higher than those not related to complex disease (the background
mRNAs; controls) by using Mann–Whitney (MW) U test (p-
value 6 9.7  1040 and p-value 6 2.6  1056 for LCL and liver,
respectively) (Fig. 4A and C; data of other cutoffs not shown). Fur-
ther analysis corroborated our findings. QQ-plots reveal that the. It is a greedy algorithm inspired from average linkage algorithm [32]. The LD cutoff
Fig. 4. Enrichment of mRNA master integrators in eQTL association networks. mRNAs of complex diseases tended to possess a large node degree (superior mRNA hubness)
than those not related to complex diseases in both LCL cell lines (Panels A and B) and liver tissue (Panels C and D). The enrichment of mRNA master integrators is retained in
each disease class level (Panels A and C). The proportion of master integrators (mRNA hubs) in each disease class is significantly more than the expected 20% (Panels A and C;
third column of legend): for LCL eQTL p 6 104, 36.4–65.6% of mRNAs are hubs in the eQTL network (Panel A; 10161 < p < 106; one tail MW p-value significance, class ranked
by median mRNA hubness) while for liver tissue eQTL p 6 105, the corresponding proportion is 45.1–67.9% (Panel C; 1040 < p 6 0.038; one tail MW test).
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cantly different in both the LCL and liver tissues (Fig. 4B and D).
More importantly, we observed that all complex disease classes
tended to comprise mRNAs with high degree of hubness in both
LCL cell lines and liver tissue (Fig. 4A and C). We also assessed
the enrichment of master integrators in each class of complex dis-
eases through randomization (See Section 2). Interestingly, the
results from randomization-based analysis matched those gener-
ated from Mann–Whitney U test (Fig. 5). These findings imply that
the enrichment of mRNAs with high connectivity values is an
inherent property of complex diseases irrespective of specific dis-
ease class.
Due to the possibility of variants affecting mRNA being in link-
age disequilibrium, thus confounding the results of master integra-
tor enrichment, we clustered SNPs associated with the same
mRNAs at various range of r2 cutoffs, specifically at values 0.8,
0.5, 0.3, 0.1 and 0.01, and retrieved the independent SNPs (See Sec-
tion 2). Even with this measure, we observed that our results
remain reproducible in the two cell lines under study (Fig. 6).
Furthermore, we observed that shared mRNAs across various
classes of complex diseases do not confound our findings. Once
we removed from 12% to 44% of mRNAs that are related to at least
two disease classes, the majority of disease classes still showed a
higher degree of enrichment with master integrators (data not
shown). The data indicates that enrichment of distinct disease
classes with highly connected mRNAs is an inherent property of
the transcriptome network inferred from the associations between
mRNAs and complex disease-associated SNPs, both intragenic and
intergenic.We also focused on the master integrators of individual com-
plex diseases to see whether our results were due to a mere aggre-
gate effect. Specifically, we ranked the complex diseases according
to the enrichment of mRNA hubness as compared to the back-
ground. The top 10 diseases/traits were tissue/cell line relevant,
in addition to a 50% overlap (Tables 2 and 3). Moreover, the mem-
bership of the top 10 was roughly consistent across various p-value
cutoffs. This indicates that the enrichment of mRNA hubness con-
verged on disease class levels despite the heterogeneity of individ-
ual complex diseases.
Finally, we studied the interconnection between mRNA hubness
and protein hubness. Overall, there is a slight correlation between
eQTL mRNA hubness and protein interaction hubness (correla-
tion = 0.037, Spearman; OR = 1.27, p = 0.0015, FET). No consistent
enrichment was observed for any disease class between mRNA
master integrators and protein centralities (either hubness). For
specific diseases/traits, only a few traits related to specific protein
functions, such as proinsulin levels and fasting glucose-related
traits, indicated a moderate of enrichment between master inte-
grators and protein hubs. These observations suggest polymor-
phisms perturbing mRNA expressions and protein interactions
likely involve different mechanisms.
4. Discussion
Previous studies have focused primarily on the assessment of
the centrality on one scale of ‘omic data by defining nodes as
genetic variants, mRNAs, or proteins. These studies do not investi-
gate the centrality of mRNAs in disease network across two scales
Fig. 5. Random sampling studies reemphasize the enrichment of master integrators in eQTL association networks. Stars (⁄) represent the observed proportions of master
integrators in the eQTL network for the disease classes. The statistical significance of the proportion of master integrators was studied using random sampling from the same
eQTL association network as that in theoretical statistics, with eQTL p-values 6 104 for LCL (Panel A) and 6 105 liver tissues (Panel B) (Methods). Empirical studies yielded
the same enrichment results as those given by the Mann–Whitney U test (Fig. 4), which indicates that theoretical statistics work for this study. Boxplots show the null
distribution of the proportion of master integrators (mRNAs with top 20% of connectivity to SNPs) generated through randomization.
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of mRNAs. In eQTL networks, mRNA regulation works through
the cumulative effect of multiple upstream genetic variants. The
findings in the current study contrast mRNA master integrators,
which respond to multiple genetic polymorphisms, with hubs in
co-expression and protein interaction networks (Fig. 1). Indeed,
disrupting an mRNA master integrator has a local effect while dis-
rupting a co-expression of a protein interaction hub has far reach-
ing consequences to deregulate the network. In addition,
deregulation of hubs in undirected protein interaction networks
may cause the deregulation of their direct interaction neighbors.
Paradoxically, in directed bipartite eQTL networks where SNPs
may regulate directly or indirectly mRNA expression, mRNA mas-
ter integrators are highly constrained mRNAs for which the regula-
tion is coordinated by the summative effect of multiple upstream
genetic signals (eQTL SNPs). In other words, complex diseases with
high percentage of mRNA master integrators (in eQTL networks),
such as systematic lupus erythematosus, are less sensitive to a sin-
gle SNP perturbation than those with lower percentage of mRNA
master integrators.
In this work, we derived mRNA networks of two cell lines/tis-
sues from their corresponding eQTL data since this type of data
makes the connection between two biological scales possible. We
then computed the hubness centrality of mRNAs in these eQTL net-
works. In doing so, we find that mRNAs associated with complex
disease SNPs are more likely to possess higher node degrees. In
other words, mRNA associated with complex disease polymor-
phism via eQTL studies are perturbed by a large number of distinct
polymorphisms, thus showing high responsiveness to the genetic
architecture.
These complex disease-related mRNA master integrators in
eQTL networks may correspond to the mRNAs that are susceptible
to diseases due to multiple perturbations. Our observation is
robust and reproducible across various ranges of eQTL p-value cut-
offs, different tissue/cell types, and distinct values of linkage dise-
quilibrium. We further corroborated our findings through
randomization. The robustness of our results shows that theenrichment of mRNA master integrators in eQTL networks of com-
plex diseases is likely an inherent property of complex disease
classes.
Our results provide new insights to the genetic architecture of
complex diseases. In accordance with our findings, a large number
of genetic variants may perturb complex diseases, which in turn
alter the expression of many mRNAs, both of which have small
effect sizes. Our results further suggest that the larger number of
genetic variations may perturb the expression of complex disease
genes, thus making the interconnectivity between genetic variants
and gene expression more complicated than expected. In other
words, this study suggests an intermediate level of leveraging sig-
nal integration between SNP and diseases by mRNA master inte-
grators and implies the robustness of the human organism upon
individual perturbations. Because distinct SNPs, associated with
distinct diseases in GWAS, may influence the expression level of
the same mRNA, this observation provides insight into the possible
role of mRNA master integrators as a mechanism of pleiotropy.
In our measurement of hubness centrality of complex disease-
related genes, we computed both the number of associated SNPs
regardless of LD and the number of independent SNPs in eQTL net-
works derived from a clustering approach. The rationale for this
strategy is that both measures correspond to some biological
mechanisms. Studies have shown that even SNPs in LD may coop-
eratively regulate the downstreammRNAs, such as by working as a
part of two enhancers to regulate the target genes [8]. In other
words, LD SNPs, although not distinguishable in eQTL associations,
are not completely functionally redundant. On the other hand,
independent SNPs without sufficient LD are inherited separately
and are thus more likely to possess independent, distinct function
mechanisms, with respect to the same mRNA. Therefore, they are
distinct sources of perturbation for the expression of mRNAs and,
consequently, distinct sources of the underlying complex disease.
However, our findings should be interpreted with caution
because of the predictions derive from five datasets. First, we sim-
ply defined the mRNAs associated with trait-associated SNPs in
eQTL studies as related mRNAs of complex diseases, but did not
Fig. 6. Enrichment of master integrators in mRNAs associated with complex disease SNPs under the linkage disequilibrium control (LD r2 < 0.01). Master integrators was
enriched in mRNAs related to complex disease by eQTL and GWAS associations even under the control of linkage disequilibrium (number of SNPs with LD r2 < 0.01) in LCL cell
lines (Panel A to D) and liver tissue (Panel E to H). The enrichment remained in each disease class level (Panel A, C, E and G). For LCL cell lines, the p-value for Mann–Whitney U
test is at most 0.02 but down to 1.4  1063 for any disease class at an LCL p-value cutoff of 104 (Panel A) and 106 (Panel C). For liver tissue with eQTL p 6 105 and 106,
hubness centrality was enriched in all disease classes except radiographic parameter traits (1.3  1038 6 p 6 0.023; one tail MW test; Panel E and G). Analysis of hubness
centrality among complex disease-related mRNAs also shows that the enrichment of mRNA master integrators is stronger with increasing strength of eQTL associations. The
boxplot of the hubness for mRNAs under eQTL p-value cutoffs of 104–106 demonstrated this trend: mRNA hubness shifts from the left (small node degrees) to the right
(Panel A vs C, Panel E vs G); complex disease-related mRNAs render larger deviations on hubness between the two groups of distributions (Panel B, D, F, and H) for more
stringent eQTL. For instance, 25 out of 26 mRNAs associated with diabetes and all 20 mRNAs associated with kidney, lung and liver diseases are master integrators at LCL eQTL
p 6 106.
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Table 2
Top 10 complex diseases derived from LCL cell lineswith enriched master integrators under LD control. Numbers of master integrators (#hub) indicate those among the top 20% of
scores of adjusted node degree of independent SNPs (r2 < 0.01). The significance of the enrichment for the mRNA master integrators as compared to other mRNAs not related to
the disease was yielded by Mann–Whitney U test. Complex diseases are ranked according to the significance under eQTL p 6 106. Bolded diseases are those consistent with that
of liver tissues. Of note, 8 out of 10 are autoimmune diseases.
Disease class Complex disease eQTL p 6 106 eQTL p 6 105 eQTL p 6 104
#hub Significance⁄ #hub Significance⁄ #hub Significance⁄
Autoimmune disease Systemic lupus erythematosus 29 1.4  1016 56 4.6  1026 93 3.4  1019
Autoimmune disease Multiple sclerosis 19 1.3  1012 35 1.0  1013 107 1.0  1013
Autoimmune disease Rheumatoid arthritis 20 8.5  1014 27 7.6  1014 62 1.5  1015
Diabetes Type 1 diabetes 19 3.4  1013 22 2.9  109 62 1.4  105
Autoimmune disease Asthma 25 4.0  1017 26 1.9  1015 35 2.3  109
Autoimmune disease Ulcerative colitis 18 1.6  1012 21 7.0  1012 44 3.8  109
Serum metabolites Hypothyroidism 17 6.6  1012 20 1.2  1011 39 1.3  1014
Autoimmune disease Systemic sclerosis 19 3.4  1013 24 1.4  1014 21 1.5  106
Autoimmune disease Immunoglobulin A 18 1.4  1012 18 1.3  1010 19 8.6  108
Autoimmune disease Inflammatory bowel disease 17 6.5  1012 16 1.6  109 15 1.3  107
Table 3
Top 10 complex diseases derived from liver tissue with enriched master integrators under LD control. Number of master integrators (#hub) corresponds to those among the top
20% of scores of adjusted node degree of independent SNPs (r2 < 0.01). The significance of the enrichment for the mRNA master integrators as compared to other mRNAs not
related to the disease was yielded by Mann–Whitney U test. Complex diseases are ranked according to the significance at eQTL p 6 106. Bolded diseases are consistent with those
of LCL cell lines. Of note, 6 out of 10 are autoimmune diseases.
Disease class Complex disease eQTL p 6 106 eQTL p 6 105
#hub Significance⁄ #hub Significance⁄
Autoimmune disease Systemic lupus erythematosus 16 3.2  1010 31 3.5  1013
Neurological behavior Cognitive performance 5 1.6  104 24 2.6  1011
Autoimmune disease Asthma 10 1.6  105 15 1.7  106
Quantitative traits Skin pigmentation 6 3.2  105 17 1.9  1012
Autoimmune disease Immunoglobulin A 8 4.7  106 11 1.8  106
Autoimmune disease Celiac disease 8 1.5  105 11 1.3  104
Autoimmune disease Inflammatory bowel disease 7 1.2  105 9 1.3  105
Cancer Hodgkin’s lymphoma 6 8.3  105 9 1.9  105
Autoimmune disease Rheumatoid arthritis 5 2.1  104 10 4.3  105
Cancer Nodular sclerosis Hodgkin lymphoma 6 3.7  105 8 6.6  105
H. Li et al. / Journal of Biomedical Informatics 58 (2015) 226–234 233confirm through case-control transcriptome studies that these
mRNAs are indeed observed as dysregulated in transcriptomemea-
surements. Second, we counted the SNPs associated with an mRNA
in measuring the hubness of the mRNA, regardless of the SNPs to
disease association. In the future, we will focus studies on intra-
genic SNPs leveraging high confidence predictions of the mecha-
nism associated with the polymorphisms using bioinformatics
software such as MutationTaster [33] and SNPdryad [34]. Third,
we analyzed eQTL data derived from only two cell types; more cell
lines or tissue eQTL, such as those from GTEx [35], should be inves-
tigated to reinforce reproducibility in the future. Fourth, our
genetic variant data covers a range of common SNPs limited to
those with significant eQTL associations. Fifth, the current
approach was based on eQTL studies that did not measure alterna-
tive splicing transcripts of a gene. One interpretation of our results
could be that mRNA hubness is confounded with distinct alterna-
tive splicing variants specific to each eQTL-associated SNP [36].
As alternative splicing eQTL data of a recent study has become
available [37], we intend to follow-up to characterize further
mRNA hubness mechanisms. Additionally, more computational
methods, such as other permutation and clustering strategies
including adaptive and non-random clustering, could have been
be used to substantiate the findings. Although enrichment was
diminished when using over-conservative control (using SNPs in
eQTL networks unrelated to the disease class as a control rather
than all SNPs regardless of their eQTL association), further verifica-
tion is needed [33,34].5. Conclusions
Network theory has increased our knowledge of the higher
order characteristics of various classes of human diseases, both
complex and Mendelian. Among the distinct properties of disease
networks, protein interaction hubness centrality of nodes is of bio-
logical and clinical importance due to its correlation with lethality;
however, studies have seldom investigated the network properties
of regulatory networks that are perturbed by intergenic SNPs.
Using eQTL network centrality metrics, our study shows that
mRNAs associated with SNPs of complex diseases are systemati-
cally more likely to be master integrators than mRNAs associated
with non-disease SNPs in significant eQTL associations. Further,
we confirm this pattern within each complex disease class and ver-
ify that these mRNA master integrators are independent of the
hubs of the proteins coded by these mRNAs. Our findings provide
novel insights into the possible pleiotropy of mRNAs targeted by
complex disease polymorphisms and the architecture of the infor-
mation flow between the genetic polymorphisms and transcrip-
tomes of complex diseases. Despite the limitations of our study,
our findings are still of clinical importance, as they indicate that
the mRNA expression values of the genes contributing to the devel-
opment and progression of complex disease are associated with an
increasing number of genetic variations. The findings outlined here
highlight the importance of developing combinatorial therapy
approaches with the ultimate goal of improving quality of life for
patients.
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